Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Wiseman

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Journal of the Royal Society for the Promotion of Health|December 13, 2003
Gene therapies for diabetesAlan Wiseman
Biologist (London, England)|February 15, 2003
Toxic residues?Alan Wiseman
Medical Hypotheses|October 11, 2005
Oxygen-induced reperfusion-injury is caused by ROS: Amelioration is possible by recombinant-DNA antioxidant enzymes and mimics in selected tissuesAlan Wiseman
Medical Hypotheses|May 17, 2005
p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzymeAlan Wiseman
Medical Hypotheses|March 28, 2006
Promiscuous-binding of insulin to adipocyte receptors in diabetes mellitus type 2 may be associated with overproduction of cyclic AMP (cAMP)Alan Wiseman
The Journal of the Royal Society for the Promotion of Health|August 1, 2006
Statins in the prevention and treatment of senile 'dementias'?Alan Wiseman
Biotechnology Letters|October 31, 2003
Replacement of immobilised cell bioreactors by smaller immobilised enzyme bioreactors: unique-outcome predictability for cytochromes P450 isoforms?Alan Wiseman
Trends in Biotechnology|December 24, 2003
Greener vaccine production with GM yeastsAlan Wiseman
Medical Hypotheses|February 8, 2005
Elimination of major side effects due to ROS of therapeuticals through biotransformation control of the 57 cytochromes P450 isoenzymesAlan Wiseman
Medical Hypotheses|August 30, 2005
Therapeutic-antagonists of oestrogens can be produced for cancer and other therapies using cytochromes P450 (CYP)Alan Wiseman
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of the Royal Society for the Promotion of Health|December 13, 2003
Gene therapies for diabetesAlan Wiseman
Biologist (London, England)|February 15, 2003
Toxic residues?Alan Wiseman
Medical Hypotheses|October 11, 2005
Oxygen-induced reperfusion-injury is caused by ROS: Amelioration is possible by recombinant-DNA antioxidant enzymes and mimics in selected tissuesAlan Wiseman
Medical Hypotheses|May 17, 2005
p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzymeAlan Wiseman
Medical Hypotheses|March 28, 2006
Promiscuous-binding of insulin to adipocyte receptors in diabetes mellitus type 2 may be associated with overproduction of cyclic AMP (cAMP)Alan Wiseman
The Journal of the Royal Society for the Promotion of Health|August 1, 2006
Statins in the prevention and treatment of senile 'dementias'?Alan Wiseman
Biotechnology Letters|October 31, 2003
Replacement of immobilised cell bioreactors by smaller immobilised enzyme bioreactors: unique-outcome predictability for cytochromes P450 isoforms?Alan Wiseman
Trends in Biotechnology|December 24, 2003
Greener vaccine production with GM yeastsAlan Wiseman
Medical Hypotheses|February 8, 2005
Elimination of major side effects due to ROS of therapeuticals through biotransformation control of the 57 cytochromes P450 isoenzymesAlan Wiseman
Medical Hypotheses|August 30, 2005
Therapeutic-antagonists of oestrogens can be produced for cancer and other therapies using cytochromes P450 (CYP)Alan Wiseman
Pageof 3